Onderneming Alliqua Biomedical Inc Nasdaq
Aandelen
US0196213096
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 01-10-07 |
Rick Orr
CEO | Chief Executive Officer | - | 01-12-10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 01-01-10 |
William Martin
PRN | Corporate Officer/Principal | - | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 01-01-08 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Rick Orr
CEO | Chief Executive Officer | - | 01-12-10 |
Matthew Ruth
BRD | Director/Board Member | - | 06-05-19 |
Julien Mamet
FOU | Founder | - | 01-10-07 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 807 877 | 5 807 877 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Adynxx, Inc.
100 Pine Street Suite 500
94111, San Francisco
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,25% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,50% | 24,63 mld. | |
-23,51% | 18,2 mld. | |
+26,87% | 12,01 mld. | |
-3,12% | 11,76 mld. | |
+14,05% | 10,4 mld. | |
-4,29% | 9,94 mld. |